Newronika’s DBS device gains CE Mark approval for Parkinson’s

by
The device aims to offer an alternative for Parkinson’s disease and other neurological conditions. Credit: Chinnapong / Shutterstock.

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson’s disease (PD), in Europe.

This closed-loop deep brain stimulation (DBS) device claims to…

Source link

Related posts:

  1. Innovative brain tumor model offers hope for personalized cancer treatments
  2. Aargau’s COVID-19 Exposure: Insights into Regional Coronavirus Resistance Trends
  3. WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications
  4. Study shows brain estrogen directly regulates appetite in mice

Leave a Comment